Company Encyclopedia
View More
name
Aktis Oncology
AKTS.US
Aktis Oncology, Inc. develops and manufactures precision radiopharmaceutical therapies for cancer treatment. The company focuses on solid tumors with limited treatment options, engineering targeted therapies that utilize alpha-emitting particles to deliver cancer-killing effects while minimizing exposure to healthy tissue. It employs a theranostic approach, using imaging tools to visualize and verify tumor targeting, and to predict patient response.
1.899 T
AKTS.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More